AB036. Comparison of the effectiveness of gefitinib, erlotinib and afatinib in epidermal growth factor receptor mutated tumors of non-small cell lung cancer

The non-small cell lung cancer (NSCLC) accounts approximately 85% of lung cancers and includes predominantly adenocarcinomas, which is the most common type and squamous cell carcinomas. The treatment options include surgery, radiation therapy, and chemotherapy and the decision depends on the patient...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Papathanasiou, Maria, Lambaki, Sofia, Porpodis, Konstantinos, Spyratos, Dionysios, Tryfon, Stayros, Zarogoulidis, Paulos, Eleytheriadoy, Ellada, Kontakiotis, Theodoros
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2016
Assuntos:
Abstract
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159369/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB036
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares